Quantum-Si (QSI)
1.25
0.08 (6.84%)
At close: Apr 11, 2025, 3:59 PM
1.24
-0.40%
After-hours: Apr 11, 2025, 05:54 PM EDT
Company Description
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing.
It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing.
The company was incorporated in 2013 is based in Guilford, Connecticut.
Quantum-Si

Country | United States |
IPO Date | Nov 13, 2020 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 149 |
CEO | Jeffrey Alan Hawkins |
Contact Details
Address: 530 Old Whitfield Street Guilford, Connecticut United States | |
Website | https://www.quantum-si.com |
Stock Details
Ticker Symbol | QSI |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001816431 |
CUSIP Number | 74765K105 |
ISIN Number | US74765K1051 |
Employer ID | 85-1388175 |
SIC Code | 3829 |
Key Executives
Name | Position |
---|---|
Jeffrey Alan Hawkins | President, Chief Executive Officer & Director |
Jeffry R. Keyes CPA | Chief Financial Officer & Treasurer |
Todd Rearick | Chief Technology Officer |
Dr. Christian Lapointe J.D., Ph.D. | General Counsel & Corporate Secretary |
Dr. John S. Vieceli Ph.D. | Chief Product Officer |
Dr. Jonathan M. Rothberg Ph.D. | Founder & Executive Director |
Katherine Atkinson | Senior Vice President of Demand Generation & Corporate Brand |
Lindsay Thompson | Chief Human Resources Officer |
Todd C. Bennett | Chief Commercial Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 10, 2025 | 8-K | Current Report |
Mar 24, 2025 | 4 | Filing |
Mar 24, 2025 | 4 | Filing |
Mar 24, 2025 | 4 | Filing |
Mar 24, 2025 | 4 | Filing |
Mar 20, 2025 | ARS | Filing |
Mar 20, 2025 | DEFA14A | Filing |
Mar 20, 2025 | DEF 14A | Filing |
Mar 14, 2025 | 4 | Filing |
Mar 14, 2025 | 4 | Filing |